Abstract 10351: Validity and Relevance of Clinical Worsening as a Composite Endpoint in Pulmonary Arterial Hypertension Trials

Background: Clinical worsening (CW) is commonly used as an endpoint in pulmonary arterial hypertension (PAH) trials. The use of composite endpoints is based on the assumption that each component is...